GLYCOMIMETICS INC (GLYC) Stock Price, Quote, News and Overview
NASDAQ:GLYC - Nasdaq - US38000Q1022 - Common Stock - Currency: USD
GLYC Quote, Performance and Key Statistics
0.2616
0 (-0.46%)
The current stock price of GLYC is 0.2616 USD. In the past month the price increased by 41.33%. In the past year, price decreased by -85.7%.
GLYC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.33 | 351.09B | ||
| AMGN | AMGEN INC | 13.55 | 151.20B | ||
| GILD | GILEAD SCIENCES INC | 13.4 | 129.08B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1728.1 | 128.84B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.67 | 65.39B | ||
| ARGX | ARGENX SE - ADR | 341.93 | 39.67B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 33.74B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.57B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.23B | ||
| NTRA | NATERA INC | N/A | 21.30B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 20.72B | ||
| BIIB | BIOGEN INC | 7.81 | 18.10B |
Related stock screener links
About GLYC
Company Profile
GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The company went IPO on 2014-01-10. The firm has no ongoing operations, is not performing any research and development, and is preserving cash until the contemplated merger and private placement. The firm was developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation.
Company Info
GLYCOMIMETICS INC
9708 Medical Center Drive
Rockville MARYLAND 20850 US
CEO: Rachel K. King
Employees: 4
Phone: 12402431201
GLYCOMIMETICS INC / GLYC FAQ
What is the stock price of GLYCOMIMETICS INC today?
The current stock price of GLYC is 0.2616 USD. The price decreased by -0.46% in the last trading session.
What is the ticker symbol for GLYCOMIMETICS INC stock?
The exchange symbol of GLYCOMIMETICS INC is GLYC and it is listed on the Nasdaq exchange.
On which exchange is GLYC stock listed?
GLYC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GLYCOMIMETICS INC stock?
7 analysts have analysed GLYC and the average price target is 1.02 USD. This implies a price increase of 289.91% is expected in the next year compared to the current price of 0.2616. Check the GLYCOMIMETICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GLYCOMIMETICS INC worth?
GLYCOMIMETICS INC (GLYC) has a market capitalization of 16.88M USD. This makes GLYC a Nano Cap stock.
How many employees does GLYCOMIMETICS INC have?
GLYCOMIMETICS INC (GLYC) currently has 4 employees.
What are the support and resistance levels for GLYCOMIMETICS INC (GLYC) stock?
GLYCOMIMETICS INC (GLYC) has a support level at 0.25 and a resistance level at 0.27. Check the full technical report for a detailed analysis of GLYC support and resistance levels.
Should I buy GLYCOMIMETICS INC (GLYC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GLYC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GLYC, evaluating the profitability, health, valuation and growth aspects
- GLYCOMIMETICS INC (GLYC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GLYCOMIMETICS INC (GLYC) Sales and EPS estimates to see what analysts future expectations are.
- GLYCOMIMETICS INC (GLYC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GLYCOMIMETICS INC (GLYC) Insider and Institutional Ownership to learn about the owners and their transactions.
- GLYCOMIMETICS INC (GLYC) Stock Chart to make your own analysis
- GLYCOMIMETICS INC (GLYC) Latest news and press-releases to stay up to date.
Does GLYCOMIMETICS INC (GLYC) stock pay dividends?
GLYC does not pay a dividend.
When does GLYCOMIMETICS INC (GLYC) report earnings?
GLYCOMIMETICS INC (GLYC) will report earnings on 2025-05-07.
What is the Price/Earnings (PE) ratio of GLYCOMIMETICS INC (GLYC)?
GLYCOMIMETICS INC (GLYC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.59).
What is the Short Interest ratio of GLYCOMIMETICS INC (GLYC) stock?
The outstanding short interest for GLYCOMIMETICS INC (GLYC) is 3.14% of its float. Check the ownership tab for more information on the GLYC short interest.
GLYC Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to GLYC. When comparing the yearly performance of all stocks, GLYC is a bad performer in the overall market: 91.87% of all stocks are doing better.
GLYC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GLYC. GLYC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
GLYC Financial Highlights
Over the last trailing twelve months GLYC reported a non-GAAP Earnings per Share(EPS) of -0.59. The EPS decreased by -1.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -341.52% | ||
| ROE | -712.87% | ||
| Debt/Equity | 0 |
GLYC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to GLYC. The Buy consensus is the average rating of analysts ratings from 7 analysts.